Skip to content

Feed Screener Search Methodology

SEC · FI · BAFIN · AFM · AMF

Pricing Sign in

InsiderLens

Statistics predict. AI explains.

Insider transactions from public regulatory disclosures, aggregated and enriched with deterministic statistical signals. Not investment advice.

Sources

SEC EDGAR · US
FINANSINSPEKTIONEN · SE
BAFIN · DE
AFM · NL
AMF · FR

Product

Methodology
Privacy notice
Object to processing

Feed Screener Search Methodology

Pricing Sign in

Shenandoah Acquisition Corp — Sigilon Therapeutics, Inc. insider: 1 transactions · InsiderLens

Home / Insiders / Shenandoah Acquisition Corp

Shenandoah Acquisition Corp

10% owner at Sigilon Therapeutics, Inc. · on record since Aug 14, 2023

Insider trading activity of Shenandoah Acquisition Corp

Transactions on record: 1; since Aug 14, 2023

Open-market buys: 1; $25.6M

Open-market sells: 0

Companies traded: 1; last filing Aug 14, 2023

Figures computed from official regulatory filings — methodology.

Companies where Shenandoah Acquisition Corp has traded

Sigilon Therapeutics, Inc.1 tx · $25.6M · Aug 14, 2023

Track record of Shenandoah Acquisition Corp

Insufficient history for a statistical track record (fewer than 5 open-market buys).

Transaction history of Shenandoah Acquisition Corp

Co-insiders of Shenandoah Acquisition Corp

AFEYAN NOUBARSigilon Therapeutics, Inc.
ANDERSON DANIEL GRIFFITHSigilon Therapeutics, Inc.
Ashton-Rickardt PhilipSigilon Therapeutics, Inc.
Cole Douglas G.Sigilon Therapeutics, Inc.
CORZO DEYASigilon Therapeutics, Inc.
COX JOHNSigilon Therapeutics, Inc.
Flagship Pioneering Special Opportunities Fund II General Partner LLCSigilon Therapeutics, Inc.

This page republishes public regulatory disclosures. Concerned by this data? Exercise your right to object →

Flagship Pioneering Special Opportunities Fund II, L.P.Sigilon Therapeutics, Inc.

Flagship Ventures Fund V General Partner LLCSigilon Therapeutics, Inc.

Flagship Ventures Fund V, L.P.Sigilon Therapeutics, Inc.

Flagship Ventures Management, Inc.Sigilon Therapeutics, Inc.

Kowalsky Matthew PaulSigilon Therapeutics, Inc.

LILLY ELI & COSigilon Therapeutics, Inc.

OESTERLE STEPHEN NSigilon Therapeutics, Inc.

Orfali MaySigilon Therapeutics, Inc.

Patel KavitaSigilon Therapeutics, Inc.

Pontes JosiasSigilon Therapeutics, Inc.

Reicin GlennSigilon Therapeutics, Inc.

RUFFOLO ROBERT RSigilon Therapeutics, Inc.

Shaff Eric D.Sigilon Therapeutics, Inc.

SMITH DEVYNSigilon Therapeutics, Inc.

Story BrookeSigilon Therapeutics, Inc.

Vivaldi Coelho RogerioSigilon Therapeutics, Inc.

Yuan Qing SarahSigilon Therapeutics, Inc.

Company	Filed	Type	Qty	Price	Value · USD	Src
Sigilon Therapeutics, Inc.	Aug 14, 2023	Buy	1,718,493	14.92 USD	$25.6M	SEC